Senate GOP includes repeal of ACA individual mandate in tax reform

Republican leaders in the Senate announced Nov. 14 they will include a repeal of the Affordable Care Act’s individual mandate in their tax reform proposal. After failing numerous times to repeal and replace the ACA, GOP leaders are hoping to include the healthcare reform in the tax bill.

“We’re optimistic that inserting the individual mandate repeal would be helpful,” Senate Majority Leader Mitch McConnell, R-Kentucky, said after a Tuesday meeting.

An updated analysis from the Congressional Budget Office (CBO) estimated repeal of the individual mandate would increase the number of uninsured Americans by 13 million between 2018 and 2027. The move would reduce federal budget deficits by $338 during the same period.

“It’ll be distributed in the form of middle-income tax relief,” Thune said. “It will give us even more of an opportunity to really distribute the relief to those middle-income cohorts who could really benefit from it.”

Some of those plans were projected to destabilize the individual market in some parts of the U.S., which the CBO said wouldn’t happen if the mandate is eliminated.

“Nongroup insurance markets would continue to be stable in almost all areas of the country throughout the coming decade,” the report said.

House GOP leaders are currently deciding whether to include a similar repeal of the individual mandate in their tax bill, with an announcement expected as early as the end of the week.

""
Nicholas Leider, Managing Editor

Nicholas joined TriMed in 2016 as the managing editor of the Chicago office. After receiving his master’s from Roosevelt University, he worked in various writing/editing roles for magazines ranging in topic from billiards to metallurgy. Currently on Chicago’s north side, Nicholas keeps busy by running, reading and talking to his two cats.

Around the web

With generative AI coming into its own, AI regulators must avoid relying too much on principles of risk management—and not enough on those of uncertainty management.

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Trimed Popup
Trimed Popup